At MEDICA Messe Düsseldorf, from November 15 to 18, 2021, CHIL participated in one of the world’s most significant medical technology gatherings, navigating a landscape still shaped by pandemic-related constraints. During the exhibition, the company showcased new advancements in diagnostics, reinforced international collaborations, and addressed emerging trends in healthcare, emphasizing resilience and forward-thinking approaches.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.